Dr. Paul Beisswenger is an Endocrinologist and Professor of Medicine at the Geisel School of Medicine at Dartmouth. He has directed a productive research program over 40 years at the University of Pennsylvania and Dartmouth, investigating the biochemical basis of diabetic complications. At PreventAGE, his focus is on new biomarkers that provide early detection and the treatments to prevent and reverse them. His research has combined studies of human populations with powerful analytic laboratory techniques to address some of the important outstanding questions regarding diabetic complications. He has published over 50 scientific papers and 5 chapters, and he continues to write from his laboratory and clinical research programs.
Dr. Beisswenger also maintained a clinical practice for 37 years, with a major focus on diabetes and was named to the “Best Doctors in America” list by Woodward-White. He has been an active member of the American Diabetes Association and has been on its National Board of Directors and a number of major national committees. At Dartmouth he served as chairman of Endocrinology and Metabolism, and directed several major academic courses as well as educating health care professionals on a national and international level.